Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands; Kaiser Permanente Division of Research, Oakland, CA, USA.
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands.
Lancet Diabetes Endocrinol. 2013 Nov;1(3):183-90. doi: 10.1016/S2213-8587(13)70048-2. Epub 2013 Aug 20.
Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes.
Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates.
Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores.
To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials.
Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.
尽管 2 型糖尿病患者患痴呆症的风险是没有这种疾病的患者的两倍,但预测谁有最高的未来风险是困难的。因此,我们创建并验证了一个实用的综合风险评分,可以用来估计 2 型糖尿病患者的 10 年痴呆风险。
我们使用了来自两个纵向 2 型糖尿病患者队列(年龄≥60 岁)的 10 年随访数据(n=29961),并进行了验证(n=2413)。我们通过使用 Cox 比例风险模型评估 45 个候选预测因子来构建我们的预测模型,并根据预测因子的β系数大小为风险评分制定一个点数系统。通过判别和校准方法测试模型预测。用 Kaplan-Meier 估计计算每个分数的痴呆风险。
微血管疾病、糖尿病足、脑血管疾病、心血管疾病、急性代谢事件、抑郁、年龄和教育程度对痴呆症的预测作用最强,构成了风险评分(创建队列的 C 统计量为 0.736,验证队列为 0.746)。最低分数(-1)的痴呆风险为 5.3%(95%CI 4.2-6.3),最高分数(12-19)的痴呆风险为 73.3%(64.8-81.8)。
据我们所知,这是第一个预测 2 型糖尿病患者 10 年痴呆风险的风险评分。该评分可用于提高对认知恶化的警惕性,并选择高危患者参加临床试验。
Kaiser Permanente 社区福利、美国国立卫生研究院、乌得勒支大学、ZonMw 和富布赖特。